Briefing

Featured article

Novo Nordisk to reduce US list prices of insulin products

Also in this section

News in Numbers

Latest News

Latest Deals

Project Updates
03/24/2023 11:20:41
  • Home | Cover
  • Editor's letter
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Controlant
  • Syntegon
  • Briefing
  • News in Numbers
  • Latest News
  • Latest Deals
  • Project Updates
  • Datwyler Company Insight
  • Datwyler
  • CfPIE
  • In Depth
  • Dawn of a new indication: How to study drugs for aging 
  • Cleanroom tech tackles environmental impact of consumables
  • Tapping into digital therapeutics to improve neurological outcomes
  • CMO Moves: Regulatory catalysts for drug manufacturing – March
  • Ethics of ultra-rare disease drug development and expanded access
  • APAC early-stage innovators raise one-third less VC funds than US players
  • Zenatek Company Insight
  • BEA Technologies
  • Bio Image Systems Inc.
  • Thematic Take
  • Thematic Take: contents
  • Foreword: the transformative power of cloud
  • An introduction to cloud computing
  • A history of cloud computing
  • The impact of cloud computing on the pharmaceutical industry 
  • Applications of cloud computing in the pharmaceutical industry
  • Latest news: cloud computing in pharma
  • Q&A with GlobalData thematic analyst
  • Is RFID the future of smart labelling?
  • Cloud robotics labs are accelerating drug discovery and development
  • Leading pharma companies in the cloud computing theme
  • Deal activity related to cloud in the pharmaceutical industry since 2020
  • Cloud hiring trends in the global pharmaceutical industry since 2020
  • Cloud patent applications in the global pharmaceutical industry since 2020
  • Mentions of cloud in pharmaceutical industry company filings since 2020
  • GlobalData Thematic Intelligence
  • Pharma Sponsored Supplements
  • HOF Sonderanlagenbau
  • Thermo Fisher Scientific
  • Listings
  • Events
  • Rankings
  • Buyer's Guides
  • Next issue